Close Window  

Coated stents win qualified backing
GAITHERSBURG, Md. -- Drug-coated stents increase the risk of potentially fatal blood clots and heart attacks in some patients, but not enough to warrant limiting use of the devices, federal advisers said yesterday . (12/9/06)

Panel hints too many get coated stents
GAITHERSBURG, Md. -- Federal advisers yesterday said that drug-coated stents, which have been implanted in millions, offer clear benefits to many patients but present higher clotting risks to others, suggesting they may be overused. (12/8/06)

FDA panel examines questions raised about drug-coated stents
A Food and Drug Administration panel tomorrow will consider one of the most urgent questions in medicine: what to do about the risk of blood clots caused by drug-coated stents, tiny medical devices implanted in the arteries of millions of people. (12/6/06)

J&J buys new-generation stent maker
In an effort to create a more powerful rival to Boston Scientific Corp., healthcare giant Johnson & Johnson said late Thursday night it would pay $1.4 billion for Conor Medsystems Inc. of California, developer of a new-generation stent to repair coronary arteries. (11/18/06)

Her stent studies intrigue doctors, Wall Street
WASHINGTON -- The FedEx packages arrive at Dr. Renu Virmani's laboratory from around the world, a new one every few days. Each contains a plastic container packed with gauze. Inside the gauze is a human heart. (10/27/06)

Drug-coated stent sales hurt by clot-risk concerns
THE REGION Boston Scientific Corp. and Johnson & Johnson are losing sales of drug-coated heart stents because doctors are concerned the devices raise the risk of blood clots. Doctors have used stents, tiny mesh tubes, to prop open diseased heart blood vessels in 4 million people worldwide since 2001. Devices coated with drugs to prevent new blockages accounted for about ... (10/14/06)

Drug-coated stent sales hurt by clot-risk concerns
THE REGION Boston Scientific Corp. and Johnson & Johnson are losing sales of drug-coated heart stents because doctors are concerned the devices raise the risk of blood clots. Doctors have used stents, tiny mesh tubes, to prop open diseased heart blood vessels in 4 million people worldwide since 2001. Devices coated with drugs to prevent new blockages accounted for about ... (10/14/06)

Cells, not tools, may help repair arteries
In the past decade, artery repair has become one of the most lucrative industries in healthcare, spawning billion-dollar companies like Boston Scientific Corp. that make equipment to keep blood flowing smoothly through the body's most important vessels. (10/2/06)

Boston Scientific addresses concerns about drug-coated stents
The product is one of the biggest-selling medical devices in history. The side effect is rare and deadly. And the impact is a giant question mark hanging over Boston Scientific Corp. , the region's biggest life-science company. (9/18/06)